超声引导下经皮肝穿刺注射华蟾素治疗原发性肝癌伴门静脉癌栓的临床效果

冀建峰; 邓晓莉; 肖秋金; 杨雪

doi:10.3969/j.issn.1001-5256.2015.06.017

超声引导下经皮肝穿刺注射华蟾素治疗原发性肝癌伴门静脉癌栓的临床效果

DOI: 10.3969/j.issn.1001-5256.2015.06.017

1. 解放军第九四医院
2. 江西省儿童医院

基金项目:

江西省卫生厅中医药科研基金课题(2013A044)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2731
- HTML全文浏览量: 6
- PDF下载量: 605
- 被引次数: 0
出版历程
- 出版日期: 2015-06-20

Ultrasound-guided percutaneous cinobufagin injection for treatment of portal vein tumor thrombus in primary liver cancer patients

Research funding:

摘要

摘要:
目的探讨超声引导下经皮肝穿刺注射华蟾素治疗门静脉癌栓的临床应用价值。方法选取2009年1月-2012年3月解放军第九四医院收治的25例原发性肝癌伴门静脉癌栓患者,行超声引导下经皮肝门静脉穿刺注射华蟾素,每周3次,45周为一个疗程,治疗后观察患者的临床疗效及生存期,并比较其治疗前后的甲胎蛋白（AFP）、ALT水平。计量资料比较采用t检验。结果17例门静脉癌栓患者不同程度缓解,总有效率为68%,患者AFP及ALT水平降低,差异具有统计学意义（P<0.05）。治疗后随访3、6、12、24个月生存率分别为88%、76%、60%、32%。结论超声引导下经皮肝穿刺注射华蟾素对门静脉癌栓疗效肯定,有较好的临床使用价值。
- 肝肿瘤 /
- 门静脉癌栓 /
- 超声检查,介入性 /
- 华蟾蜍毒素
Abstract:
Objective To evaluate the clinical value of ultrasound- guided percutaneous cinobufagin injection for the treatment of portal vein tumor thrombus( PVTT) in primary liver cancer( PLC) patients. Methods A total of 25 PLC patients with PVTT who were admitted to our hospital from January 2009 to March 2012 were recruited in this study. These patients underwent ultrasound- guided percutaneous cinobufagin injection three times a week,and each course of treatment was 4- 5 weeks. After treatment,the clinical efficacy and survival rates were determined,and the changes in levels of alpha fetoprotein( AFP) and alanine aminotransferase( ALT) were evaluated. Results Seventeen patients showed varying degrees of improvement after treatment,with an overall response rate of 68%. In addition,the levels of AFP and ALT were significantly reduced after treatment( P < 0. 05). The survival rates at 3,6,12,and 24 months after treatment were88%,76%,60%,and 32%,respectively. Conclusion Ultrasound- guided percutaneous cinobufagin injection has good efficacy in the treatment of PVTT in PLC patients and shows a good clinical value.
- liver neoplasms /
- portal vein tumor thrombosis /
- ultrasonography,interventional /
- cinobufagin

HTML全文

参考文献(16)

[1]LIN JQ,YANG WZ,JIANG N,et al.CT-guided iodine-125 seed implantation in the treatment of primary hepatocellular carcinoma combined with portal vein tumor thrombus[J].Chin J Interv Imaging Ther,2011,8(4):299-302.(in Chinese)林俊清,杨维竹,江娜,等.CT引导下125I放射性粒子植入治疗原发性肝细胞癌伴门静脉癌栓[J].中国介入影像与治疗学,2011,8(4):299-302.

[2]NISHIKAWA H,INUZUKA T,TAKEDA H,et al.A case of advanced hepatocellular carcinoma with portal vein tumor thrombus refractory to epirubicin that showed marked decrease in tumor markers after transcatheter arterial infusion with miriplatin[J].Case Rep Oncol,2011,4(2):327-335.

[3]GIANNELLI G,PIERRI F,TREROTOLI P,et al.Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival.A retrospective clinical study of 150 cases[J].Hepatol Res,2002,24(1):50.

[4]QUIRK M,KIM YH,SAAB S,et al.Management of hepatocellular carcinoma with portal vein thrombosis[J].World J Gastroenterol,2015,21(12):3462-3471.

[5]SUN HT,ZHAO WW,CHEN ZM,et al.Clinical observation of microwave ablation combined with portal vein perfusion chemotherapy in the treatment of hepatocellular carcinoma combined with portal vein tumor thrombus[J].China Med Herald,2013,10(6):82-84.(in Chinese)孙厚坦,赵威武,陈朝旻,等.微波消融结合门静脉灌注治疗肝癌合并门静脉癌栓的临床观察[J].中国医药导报,2013,10(6):82-84.

[6]TAWADA A,CHIBA T,OOKA Y,et al.Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma[J].Anticancer Res,2014,34(8):4231-4237.

[7]SOFUE K,ARAI Y,SHIMADA K,et al.Right portal vein embolization with absolute ethanol in major hepatic resection for hepatobiliary malignancy[J].Br J Surg,2014,101(9):1122-1128.

[8]ZHENG JS,LONG J,SUN B,et al.Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis:extending the indication for ablation?[J].Clin Radiol,2014,69(6):253-263.

[9]ISHIKAWA T,KUBOTA T,ABE H,et al.Percutaneous transhepatic portal vein stent placement can improve prognosis for hepatocellular carcinoma patients with portal vein tumor thrombosis[J].Hepatogastroenterology,2014,61(130):413-416.

[10]YAMAMOTO Y,IKOMA H,MORIMURA R,et al.Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis[J].World J Gastroenterol,2015,21(1):246-253.

[11]SHI J,LAI EC,LI N,et al.A new classification for hepatocellular carcinoma with portal vein tumor thrombus[J].J Hepatobiliary Pancreat Sci,2011,18(1):74-80.

[12]CHENG SQ,LI N,WU MC.Treatment choice on hepatocellular carcinoma with different types of portal vein tumor thrombus[J].Chin J Bases Clin General Surg,2012,19(3):240-242.(in Chinese)程树群,李楠,吴孟超.门静脉癌栓分型与治疗选择[J].中国普外基础与临床杂志,2012,19(3):240-242.

[13]QIAO L,GAO JF,LI N,et al.The study of recent curative effect of injection tumor body with Chinese herbs preparation via puncturing skin and liver through color ultrasonic induction[J].J Ultrasound Clin Med,2005,7(1):31-33.(in Chinese)谯朗,高俊飞,李娜,等.彩超引导下经皮肝穿刺瘤体内注射中药制剂治疗肝癌的近期疗效观察[J].临床超声医学杂志,2005,7(1):31-33.

[14]FAN SH,LI MX.Status of hepatic carcinoma treatment by ultrasonic-guided percutaneous intervention[J].China Med Herald,2014,11(7):159-162.(in Chinese)樊树华,李明星.超声引导经皮介入治疗肝癌的现状[J].中国医药导报,2014,11(7):159-162.

[15]WANG TT,XU GX.Advancement on study of pharmacological action and clinical application of cinobufotalin[J].Int J Ophthalmol,2009,9(7):1330-1333.(in Chinese)王婷婷,徐国兴.华蟾素的药理作用研究及临床应用进展[J].国际眼科杂志,2009,9(7):1330-1333.

[16]CAO YJ,YANG JK,YANG JZ.Research advance in treatment of primary liver cancer with cinobufacini injection[J].Shanghai J Tradit Chin Med,2012,46(4):86-88.(in Chinese)曹亚娟,杨金坤,杨金祖.华蟾素注射液治疗原发性肝癌研究进展[J].上海中医药杂志,2012,46(4):86-88.

施引文献

资源附件(0)

访问统计